January 6, 2026

How low can you go (and still build muscle)? Why strength training matters at any age

by Tom Janssen, Matthew Lees, The Conversation edited by Lisa Lock, reviewed by Andrew Zinin  Editors’ notes Credit: Yan Krukau from Pexels Getting out of a chair shouldn’t be a struggle. Yet for many older adults, simple everyday movements like this become increasingly difficult as our muscles break down and weaken with age, a process called sarcopenia. The consequences […]

How low can you go (and still build muscle)? Why strength training matters at any age Read More »

Diet may influence tinnitus risk in women

by Lori Solomon edited by Stephanie Baum, reviewed by Andrew Zinin  Editors’ notes Diet may influence the risk of women developing tinnitus, according to a study published online Dec. 17 in the American Journal of Epidemiology. Sharon G. Curhan, M.D., from Brigham and Women’s Hospital in Boston, and colleagues examined the longitudinal associations of diet patterns and risk for developing

Diet may influence tinnitus risk in women Read More »

Pancreatic cancer is among the deadliest cancers: New drug is giving patients and doctors hope

by Kayla Yup edited by Sadie Harley, reviewed by Andrew Zinin  Editors’ notes Axial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domain Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to stage 4 less than a year after

Pancreatic cancer is among the deadliest cancers: New drug is giving patients and doctors hope Read More »

Immune sabotage: How a Vitamin A byproduct compromises the body’s normal anti-cancer response

by Ludwig Cancer Research edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes Credit: iScience (2025). DOI: 10.1016/j.isci.2025.113675 Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by which a metabolic derivative of vitamin A—all-trans retinoic acid—compromises both the body’s normal anti-cancer immune response and, in a different context, the efficacy

Immune sabotage: How a Vitamin A byproduct compromises the body’s normal anti-cancer response Read More »

Here’s what to know about the unprecedented changes to child vaccine recommendations

by Lauran Neergaard edited by Andrew Zinin  Editors’ notes A certified medical assistant holds a syringe for a flu vaccine at a clinic in Seattle, on Wednesday, Sept. 10, 2025. Credit: AP Photo/Lindsey Wasson, File U.S. health officials made broad changes to childhood vaccine recommendations Monday, alarming pediatricians and other medical experts who say they will sow confusion

Here’s what to know about the unprecedented changes to child vaccine recommendations Read More »

Waist-to-height ratio found to be a more accurate indicator of obesity risk in older adults than BMI

by Sasha Spencer, University of Sheffield edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes Credit: CC0 Public Domain As the UK’s population continues to age, obesity and obesity-related diseases are an increasing burden on the NHS. However, the use of more accurate screening tools, such as waist-to-height ratio, could help ensure older adults at risk are

Waist-to-height ratio found to be a more accurate indicator of obesity risk in older adults than BMI Read More »

Study highlights effect of Alzheimer’s, frontotemporal dementia on subcortical brain structures

by Pat Sargent, University of Massachusetts Medical School edited by Lisa Lock, reviewed by Andrew Zinin  Editors’ notes The sTHOMAS segmentation pipeline. Credit: Human Brain Mapping (2025). DOI: 10.1002/hbm.70350 A recent study by the Laboratory for Neuro-Analysis and Imaging (LANAI) at UMass Chan Medical School highlights how subcortical brain structures degenerate in Alzheimer’s disease and frontotemporal dementia patients. The study, published in

Study highlights effect of Alzheimer’s, frontotemporal dementia on subcortical brain structures Read More »

Novo Nordisk launches Wegovy pill for as little as $25 a month for insured patients

January 5, 2026 05:09 AM ESTUpdated 08:03 AM Pharma Updated: Novo Nordisk launches Wegovy pill for as little as $25 a month for insured patients Elizabeth Cairns Senior biopharma journalist Novo Nordisk will launch the pill form of its obesity med Wegovy in the US on Monday, saying that it could cost insured patients as

Novo Nordisk launches Wegovy pill for as little as $25 a month for insured patients Read More »

Deadly flu strain grips the US for the first time and has killed 5,000 to date

By Bronwyn Thompson January 05, 2026 Facebook Twitter LinkedIn Reddit Flipboard Email The H3N2 subclade K virus has genetically drifted from earlier J.2.4 influenza A strains, and is better at evading our immune system Depositphotos View 1 Images   Americans are being urged to be extra vigilant this winter, as a suite of influenza A mutations

Deadly flu strain grips the US for the first time and has killed 5,000 to date Read More »

Scroll to Top